These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36625284)

  • 21. Structure and function of mammalian DNA ligases.
    Tomkinson AE; Mackey ZB
    Mutat Res; 1998 Feb; 407(1):1-9. PubMed ID: 9539976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human DNA ligases I, III, and IV-purification and new specific assays for these enzymes.
    Chen X; Pascal J; Vijayakumar S; Wilson GM; Ellenberger T; Tomkinson AE
    Methods Enzymol; 2006; 409():39-52. PubMed ID: 16793394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of DNA repair in the absence of classical non-homologous end joining.
    Kang YJ; Yan CT
    DNA Repair (Amst); 2018 Aug; 68():34-40. PubMed ID: 29929045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution of Mycobacterium marinum Nonhomologous DNA End Joining Pathway in
    Zhang WW; Wright DG; Harrison L; Matlashewski G
    mSphere; 2022 Jun; 7(3):e0015622. PubMed ID: 35695492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.
    Simsek D; Furda A; Gao Y; Artus J; Brunet E; Hadjantonakis AK; Van Houten B; Shuman S; McKinnon PJ; Jasin M
    Nature; 2011 Mar; 471(7337):245-8. PubMed ID: 21390132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The DNA Ligase IV Syndrome R278H Mutation Impairs B Lymphopoiesis via Error-Prone Nonhomologous End-Joining.
    Park J; Welner RS; Chan MY; Troppito L; Staber PB; Tenen DG; Yan CT
    J Immunol; 2016 Jan; 196(1):244-55. PubMed ID: 26608917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.
    Doksani Y; de Lange T
    Cell Rep; 2016 Nov; 17(6):1646-1656. PubMed ID: 27806302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repair of DNA double-strand breaks by mammalian alternative end-joining pathways.
    Sallmyr A; Tomkinson AE
    J Biol Chem; 2018 Jul; 293(27):10536-10546. PubMed ID: 29530982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative end-joining pathway(s): bricolage at DNA breaks.
    Frit P; Barboule N; Yuan Y; Gomez D; Calsou P
    DNA Repair (Amst); 2014 May; 17():81-97. PubMed ID: 24613763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-Terminal region of DNA ligase IV drives XRCC4/DNA ligase IV complex to chromatin.
    Liu S; Liu X; Kamdar RP; Wanotayan R; Sharma MK; Adachi N; Matsumoto Y
    Biochem Biophys Res Commun; 2013 Sep; 439(2):173-8. PubMed ID: 23994631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing the Repair of DNA Double-Strand Breaks: A Review of Surrogate Plasmid-Based Reporter Methods.
    Dutta A; Mitra J; Hegde PM; Mitra S; Hegde ML
    Methods Mol Biol; 2023; 2701():173-182. PubMed ID: 37574482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-tiered enforcement of high-fidelity DNA ligation.
    Tumbale PP; Jurkiw TJ; Schellenberg MJ; Riccio AA; O'Brien PJ; Williams RS
    Nat Commun; 2019 Nov; 10(1):5431. PubMed ID: 31780661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathways and outcomes of mycobacterial NHEJ depend on the structure of the broken DNA ends.
    Aniukwu J; Glickman MS; Shuman S
    Genes Dev; 2008 Feb; 22(4):512-27. PubMed ID: 18281464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70.
    Boboila C; Jankovic M; Yan CT; Wang JH; Wesemann DR; Zhang T; Fazeli A; Feldman L; Nussenzweig A; Nussenzweig M; Alt FW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3034-9. PubMed ID: 20133803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered DNA ligase activity in human disease.
    Tomkinson AE; Naila T; Khattri Bhandari S
    Mutagenesis; 2020 Feb; 35(1):51-60. PubMed ID: 31630206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV.
    Greco GE; Matsumoto Y; Brooks RC; Lu Z; Lieber MR; Tomkinson AE
    DNA Repair (Amst); 2016 Jul; 43():18-23. PubMed ID: 27235626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative NHEJ Pathway Components Are Therapeutic Targets in High-Risk Neuroblastoma.
    Newman EA; Lu F; Bashllari D; Wang L; Opipari AW; Castle VP
    Mol Cancer Res; 2015 Mar; 13(3):470-82. PubMed ID: 25563294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-stranded DNA oligomers stimulate error-prone alternative repair of DNA double-strand breaks through hijacking Ku protein.
    Yuan Y; Britton S; Delteil C; Coates J; Jackson SP; Barboule N; Frit P; Calsou P
    Nucleic Acids Res; 2015 Dec; 43(21):10264-76. PubMed ID: 26350212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organization and dynamics of the nonhomologous end-joining machinery during DNA double-strand break repair.
    Reid DA; Keegan S; Leo-Macias A; Watanabe G; Strande NT; Chang HH; Oksuz BA; Fenyo D; Lieber MR; Ramsden DA; Rothenberg E
    Proc Natl Acad Sci U S A; 2015 May; 112(20):E2575-84. PubMed ID: 25941401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
    Caracciolo D; Juli G; Riillo C; Coricello A; Vasile F; Pollastri S; Rocca R; Scionti F; Polerà N; Grillone K; Arbitrio M; Staropoli N; Caparello B; Britti D; Loprete G; Costa G; Di Martino MT; Alcaro S; Tagliaferri P; Tassone P
    J Transl Med; 2022 Oct; 20(1):482. PubMed ID: 36273153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.